Fidelity Select Biotechnology Portfolio (FBIOX) Dividend Yield, History & Forecast

Fidelity Select Biotechnology Portfolio (FBIOX) is an exchange-traded fund (ETF) listed on the NASDAQ. The most recent ex-dividend date was April 10, 2026, with payment scheduled for April 13, 2026. market capitalization is approximately $5.35B.

Loading quote...

Frequently Asked Questions about Fidelity Select Biotechnology Portfolio (FBIOX)

When does Fidelity Select Biotechnology Portfolio pay its next dividend?
The most recent ex-dividend date was April 10, 2026. The next scheduled dividend payment date is April 13, 2026.
How many years has Fidelity Select Biotechnology Portfolio increased its dividend?
Fidelity Select Biotechnology Portfolio (FBIOX) has increased its dividend for 2 consecutive years.
Is Fidelity Select Biotechnology Portfolio a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. Fidelity Select Biotechnology Portfolio (FBIOX) currently has 2 years of consecutive increases.
What sector is Fidelity Select Biotechnology Portfolio in?
Fidelity Select Biotechnology Portfolio (FBIOX) operates in the Healthcare sector, specifically the Biotechnology industry.